The cystic fibrosis N.I. Ed., Kapranov, N.Yu. Kashirskaya. [Mukovistsidoz] pod. red. N.I. Kapranov, N.Yu. Kashirskaya. Moscow; Medpractika. 2014.
Smirnov I.E., Tarasova O.V., Lukina O.F., Kustova O.V., Sorokina T.E., Simonova O.I. Structural and functional state of the lungs in cystic fibrosis in children. Rossiyskiy pediatricheskiy zhurnal. 2015; 18 (1): 14-20. (in Russian)
Blagovidov D.A., Simonova O.I., Kostinov M.P., Smirnov I.E. Pseudomonas infections in patients with chronic nonspecific pulmonary diseases and problems of its vaccine prevention. Rossiyskiy pediatricheskiy zhurnal. 2015; 18(6): 54-60. (in Russian)
Kondratieva E.I., Krasovskii S.A., Voronkova A.Yu., Amelina E.L., Chernyak A.V., Kashirskaya N.Yu. The register of patients with cystic fibrosis in the Russian Federation. 2015 year. [Registr bolnykh mukovistsidozom v Rossiyskoy Federatsii. 2015 god]. Medpractic-M, 2016. (in Russian)
Castellani C.H. Cuppens M., Macek Jr. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J. Cystic Fibr. 2008; 7(3): 179-96.
Dvoryakovskaya G.V., Simonova O.I., Ivleva S.A., Dvoryakovskiy I.V., Surkov A.N., Gorbunova M.O., Smirnov I.E. The experience of prolonged use of the inhalation solution of tobramycin in chronic Pseudomonas aeruginosa infection in children with cystic fibrosis. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii. 2014; 24 (2): 36-42. (in Russian)
Ahmed N., Corey G., Forstner D. Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the axocrine pancreas. Gut; 2003;52(8): 1152-1164.
Imrie J.R., Fagan D.G. and Sturgess J.M. Quantitative evaluation of the development of the exocrine pancreas in cystic fibrosis and control infants. Am J Pathol. 1979; 95 (3): 697-08.
Durno C., Corey M., Zielenski J., Tullis E., Tsui L.-C., and Durie P. Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology. 2002; 123(6): 1857-64.
Ooi C.Y., Dorfman R., Cipolli M., Gonska T., Castellan, C., Keenan K. et al. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology. 2011; 140 (1): 153-61.
Ooi C.Y. and Durie P.R. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis. J Cyst Fibros. 2012; 11 (5): 355-62.
Couper R.T., Corey M., Durie P.R., Forstner G.G., and Moore D.J. Longitudinal evaluation of serum trypsinogen measurement in pancreatic-insufficient and pancreatic-sufficient patients with cystic fibrosis. J Pediatr. 1995; 127 (3): 408-13.
de Cid R., Ramos M.D., Aparisi L., García C., Mora J., Estivill X. et al. Independent contribution of common CFTR variants to chronic pancreatitis. Pancreas. 2010; 39 (2): 209-15.
Noone P.G., Zhou Z., Silverman L.M., Jowell P.S., Knowles M.R., and Cohn J.A. Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology. 2001; 121 (6): 1310-9.
Schwarzenberg S.J., Bellin M., Husain S.Z., Ahuja M., Barth B., Davis H. et al. Pediatric chronic pancreatitis is associated with genetic risk factors and substantial disease burden. J Pediatr. 2015;166 (4): 890-1.
Sultan M., Werlin S., and Venkatasubramani N. Genetic prevalence and characteristics in children with recurrent pancreatitis. J Pediatr Gastroenterol Nutr. 2012; 54 (5): 645-50.
Jamer T., Iwańczak B. Genetic mutations as a cause of acute recurrent pancreatitis in children - case report and literature review. Dev Period Med. 2016; 20(3): 228-34.
Zielenski J. Genotype and phenotype in cystic fibrosis. Respiration. 2000; 67 (2): 117-33.
Dinopoulos A., Karapanou O., Alexopoulou E., Tzetis M., Attilakos A., and Fretzayas A. VPA-induced recurrent pancreatitis in a cystic fibrosis carrier. Eur J Paediatr Neurol. 2011; 15 (5): 453-5.
Morinville V.D., Husain S.Z., Bai H., Barth B., Alhosh R., Durie P.R. et al. Definitions of pediatric pancreatitis and survey of present clinical practices. J Pediatr Gastroenterol Nutr. 2012; 55 (3): 261-5.
Hammer M.M., Zhang L., Stoll J.M., and Sheybani E.F. Candida albicans pancreatitis in a child with cystic fibrosis post lung transplantation. Pediatr Radiol. 2016; 46 (4): 575-8.
Hemphill M.T., Jones K.R. Tigecycline-induced acute pancreatitis in a cystic fibrosis patient: a case report and literature review. J Cyst Fibros. 2016; 15 (1): 9-11.
Banks P.A., Bollen T.L., Dervenis C., Gooszen H.G., Johnson C.D., Sarr M.G. et al. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013; 62 (1): 102-11.
American Gastroenterological Association (AGA) Institute on «Management of Acute Pancreatits», Clinical Practice and Economics Committee, and AGA Institute Governing Board. AGA Institute medical position statement on acute pancreatitis. Gastroenterology. 2007; 132 (5): 2019-21.
Abu-El-Haija M., Lin T.K., Palermo J. Update to the management of pediatric acute pancreatitis: highlighting areas in need of research. J Pediatr Gastroenterol Nutr. 2014; 58 (6): 689-93.
Oláh A., Pardavi G., Belágyi T., Nagy A., Issekutz A., and Mohamed G.E. Early nasojejunal feeding in acute pancreatitis is associated with a lower complication rate. Nutrition. 2002; 18 (3): 259-62.
Abu-El-Haija M., Wilhelm R., Heinzman C., Siqueira B.N.F., Zou Y., Fei L. et al. Early enteral nutrition in children with acute pancreatitis. J Pediatr Gastroenterol Nutr. 2016; 62 (3): 453-6.
Schneider A., Larusch J., Sun X., Aloe A., Lamb J., Hawes R. et al. Combined bicarbonate conductance-impairing variants in CFTR and SPINK1 variants are associated with chronic pancreatitis in patients without cystic fibrosis. Gastroenterology. 2011; 140 (1): 162-71.